ERBB2 and triple-negative breast carcinoma: Molecular subtypes are classified based on hormone receptor status, Her-2 expression, and the Ki67 index, resulting in luminal A, luminal B, HER-2 positive non-luminal, and triple-negative breast cancer (TNBC) (6).